ContractRetention Benefits Agreement • November 2nd, 2020 • Minerva Neurosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2020 Company IndustryCertain identified information identified with brackets (“[•••]”) has been excluded from this exhibit because it both (i) is not material and (ii) would be competitively harmful if publicly disclosed.
ContractRetention Benefits Agreement • November 2nd, 2020 • Minerva Neurosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2020 Company IndustryCertain identified information identified with brackets (“[•••]”) has been excluded from this exhibit because it both (i) is not material and (ii) would be competitively harmful if publicly disclosed.
ContractRetention Benefits Agreement • November 2nd, 2020 • Minerva Neurosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2020 Company IndustryCertain identified information identified with brackets (“[•••]”) has been excluded from this exhibit because it both (i) is not material and (ii) would be competitively harmful if publicly disclosed.
ContractRetention Benefits Agreement • November 2nd, 2020 • Minerva Neurosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2020 Company IndustryCertain identified information identified with brackets (“[•••]”) has been excluded from this exhibit because it both (i) is not material and (ii) would be competitively harmful if publicly disclosed.
ContractRetention Benefits Agreement • November 2nd, 2020 • Minerva Neurosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2020 Company IndustryCertain identified information identified with brackets (“[•••]”) has been excluded from this exhibit because it both (i) is not material and (ii) would be competitively harmful if publicly disclosed.